Log In
BCIQ
Print this Print this
 

Zuragen (AAT-023)

  Manage Alerts
Collapse Summary General Information
Company Ash Access Technology Inc.
DescriptionAntimicrobial/antithrombotic citrate-based solution
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationBacterial infection
Indication DetailsPrevent catheter-related bloodstream infections
Regulatory Designation U.S. - Undisclosed Review (Prevent catheter-related bloodstream infections)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today